EW Edwards Lifesciences
NYSE · SEC CIK 1099800 · EDGAR
- Bought, last 12 months
- $0 0 purchases by 0 insiders
- Sold, last 12 months
- $27.68M 42 sales by 9 insiders
- Filings on record
- 445 since 2021-07-01, latest 2026-09-14 18:04
BoughtSold
Most active insiders, 12 months
| Insider | Title | Bought | Sold |
|---|---|---|---|
| BOBO DONALD E JR | CVP, Strategy, Corp Development | — | $11.15M |
| Zovighian Bernard J | CEO, Dir | — | $7.00M |
| Ullem Scott B. | CFO, CVP | — | $3.87M |
| Chopra Daveen | CVP, TMTT, Surgical, IHFM | — | $3.19M |
| Markowitz Wayne | CVP, JAPAC | — | $1.04M |
| Lippis Daniel J. | CVP, TAVR | — | $871.6K |
| Bruls Annette | CVP, EMEACLA | — | $237.9K |
| STONE HEISZ LESLIE | Dir | — | $218.1K |
| Dahl Andrew M. | SVP, Corp. Ctrl | — | $98.4K |
| Davis Leslie C. | Dir | — | — |
Transactions 820
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-05-09 | 2024-05-07 | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | F - Tax | $85.09 | -178 | 17.3K | -1% | -$15.1K |
| D | 2024-05-09 | 2024-05-07 | EW | Wood Larry L | Gbl Pres TAVR, Surg | F - Tax | $85.09 | -695 | 224.5K | -0.3% | -$59.1K |
| D | 2024-05-09 | 2024-05-07 | EW | Wood Larry L | Gbl Pres TAVR, Surg | A - Grant | $0.00 | +8,725 | 225.2K | +4% | $0 |
| D | 2024-05-09 | 2024-05-07 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | A - Grant | $0.00 | +6,700 | 48.4K | +16% | $0 |
| D | 2024-05-09 | 2024-05-07 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | F - Tax | $85.09 | -619 | 47.7K | -1% | -$52.7K |
| DI | 2024-05-07 | 2024-05-06 | EW | Zovighian Bernard J | CEO, Dir | P - Purchase | $85.74 | +580.26 | 3,268 | +22% | +$49.8K |
| DM | 2024-05-07 | 2024-05-03+ | EW | Zovighian Bernard J | CEO, Dir | F - Tax | $85.23 | -4,245 | 46.8K | -8% | -$361.8K |
| D | 2024-05-07 | 2024-05-04 | EW | Zovighian Bernard J | CEO, Dir | M - OptEx | $0.00 | +6,265 | 50.6K | +14% | $0 |
| DM | 2024-05-06 | 2024-05-03+ | EW | Szyman Catherine M. | CVP, Critical Care | F - Tax | $85.23 | -3,921 | 43.2K | -8% | -$334.2K |
| D | 2024-05-06 | 2024-05-04 | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $0.00 | +5,796 | 49.0K | +13% | $0 |
| DM | 2024-05-06 | 2024-05-03+ | EW | Ullem Scott B. | CFO, CVP | F - Tax | $85.23 | -5,065 | 18.4K | -22% | -$431.7K |
| D | 2024-05-06 | 2024-05-04 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $0.00 | +7,465 | 25.9K | +40% | $0 |
| D | 2024-05-06 | 2024-05-04 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $0.00 | +5,855 | 45.1K | +15% | $0 |
| DM | 2024-05-06 | 2024-05-03+ | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | F - Tax | $85.23 | -3,954 | 41.7K | -9% | -$337.0K |
| M | 2024-05-06 | 2024-05-03+ | EW | Lippis Daniel J. | CVP, JAPAC | F - Tax | $85.16 | -572 | 16.9K | -3% | -$48.7K |
| DM | 2024-05-06 | 2024-05-03+ | EW | Chopra Daveen | CVP, TMTT | F - Tax | $85.23 | -2,612 | 22.5K | -10% | -$222.6K |
| D | 2024-05-06 | 2024-05-04 | EW | Chopra Daveen | CVP, TMTT | M - OptEx | $0.00 | +4,713 | 27.2K | +21% | $0 |
| DM | 2024-05-06 | 2024-05-03+ | EW | Wood Larry L | Gbl Pres TAVR, Surg | F - Tax | $85.23 | -3,936 | 216.5K | -2% | -$335.5K |
| D | 2024-05-06 | 2024-05-04 | EW | Wood Larry L | Gbl Pres TAVR, Surg | M - OptEx | $0.00 | +6,675 | 220.0K | +3% | $0 |
| DM | 2024-05-06 | 2024-05-03+ | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | F - Tax | $85.23 | -296 | 173.8K | -0.2% | -$25.2K |
| D | 2024-05-06 | 2024-05-04 | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | M - OptEx | $0.00 | +4,157 | 178.0K | +2% | $0 |
| M | 2024-05-06 | 2024-05-03+ | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | F - Tax | $85.16 | -226 | 15.2K | -1% | -$19.2K |
| DM | 2024-05-02 | 2024-05-02 | EW | MUSSALLEM MICHAEL A | Dir | S - Sale+OE | $84.77 | -29.4K | 21.6K | -58% | -$2.49M |
| D | 2024-05-02 | 2024-05-02 | EW | MUSSALLEM MICHAEL A | Dir | M - OptEx | $36.75 | +29.4K | 33.8K | +654% | +$1.08M |
| D | 2024-05-01 | 2024-05-01 | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | M - OptEx | $36.75 | +14.4K | 188.2K | +8% | +$529.2K |
| DM | 2024-05-01 | 2024-05-01 | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | S - Sale+OE | $84.22 | -14.4K | 186.1K | -7% | -$1.21M |
| D | 2024-04-30 | 2024-04-30 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +7,250 | 26.3K | +38% | +$266.4K |
| DM | 2024-04-30 | 2024-04-30 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $85.80 | -7,250 | 19.1K | -28% | -$622.1K |
| D | 2024-04-09 | 2024-04-09 | EW | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $36.75 | +857 | 18.3K | +5% | +$31.5K |
| D | 2024-04-09 | 2024-04-09 | EW | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $92.34 | -857 | 17.5K | -5% | -$79.1K |
| D | 2024-04-08 | 2024-04-08 | EW | Lemercier Jean-Luc M | CVP, EMEACLA | M - OptEx | $36.75 | +14.4K | 188.2K | +8% | +$529.2K |
| DM | 2024-04-08 | 2024-04-08 | EW | Lemercier Jean-Luc M | CVP, EMEACLA | S - Sale+OE | $92.32 | -14.4K | 188.1K | -7% | -$1.33M |
| D | 2024-04-08 | 2024-04-08 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $36.75 | +12.5K | 52.3K | +31% | +$459.4K |
| DM | 2024-04-08 | 2024-04-08 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $92.33 | -12.5K | 39.8K | -24% | -$1.15M |
| DM | 2024-04-04 | 2024-04-04 | EW | MUSSALLEM MICHAEL A | Dir | S - Sale+OE | $92.42 | -29.4K | 4,486 | -87% | -$2.71M |
| D | 2024-04-04 | 2024-04-04 | EW | MUSSALLEM MICHAEL A | Dir | M - OptEx | $36.75 | +29.4K | 33.8K | +654% | +$1.08M |
| D | 2024-04-01 | 2024-04-01 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +7,255 | 26.3K | +38% | +$266.6K |
| DM | 2024-04-01 | 2024-04-01 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $94.89 | -7,255 | 25.5K | -22% | -$688.5K |
| D | 2024-03-13 | 2024-03-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $36.75 | +14.5K | 54.0K | +37% | +$532.9K |
| D | 2024-03-13 | 2024-03-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $91.01 | -14.5K | 39.5K | -27% | -$1.32M |
| D | 2024-03-11 | 2024-03-11 | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | M - OptEx | $36.75 | +14.4K | 188.0K | +8% | +$529.2K |
| D | 2024-03-11 | 2024-03-11 | EW | Lemercier Jean-Luc M | CVP, EMEACLA, JAPAC | S - Sale+OE | $91.68 | -14.4K | 173.6K | -8% | -$1.32M |
| D | 2024-03-07 | 2024-03-07 | EW | Lippis Daniel J. | CVP, JAPAC | M - OptEx | $36.75 | +1,715 | 18.9K | +10% | +$63.0K |
| D | 2024-03-07 | 2024-03-07 | EW | Lippis Daniel J. | CVP, JAPAC | S - Sale+OE | $90.98 | -1,715 | 17.2K | -9% | -$156.0K |
| D | 2024-03-04 | 2024-03-04 | EW | MUSSALLEM MICHAEL A | Dir | M - OptEx | $36.75 | +29.4K | 33.8K | +654% | +$1.08M |
| DM | 2024-03-04 | 2024-03-04 | EW | MUSSALLEM MICHAEL A | Dir | S - Sale+OE | $86.67 | -29.4K | 20.5K | -59% | -$2.54M |
| D | 2024-02-29 | 2024-02-29 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +7,255 | 26.3K | +38% | +$266.6K |
| D | 2024-02-29 | 2024-02-29 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $85.59 | -7,255 | 19.1K | -28% | -$621.0K |
| D | 2024-02-26 | 2024-02-23 | EW | GALLAHUE KIERAN | Dir | M - OptEx | $36.86 | +7,056 | 10.8K | +191% | +$260.1K |
| D | 2024-02-26 | 2024-02-23 | EW | GALLAHUE KIERAN | Dir | G - Gift | $0.00 | -7,056 | 3,701 | -66% | $0 |
| DI | 2024-02-26 | 2024-02-23 | EW | GALLAHUE KIERAN | Dir | S - Sale+OE | $87.61 | -3,058 | 67.2K | -4% | -$267.9K |
| DI | 2024-02-26 | 2024-02-23 | EW | GALLAHUE KIERAN | Dir | G - Gift | $0.00 | +7,056 | 70.3K | +11% | $0 |
| 2024-02-23 | 2024-02-22 | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | A - Grant | $0.00 | +1,998 | 15.1K | +15% | $0 | |
| 2024-02-23 | 2024-02-22 | EW | Szyman Catherine M. | CVP, Critical Care | A - Grant | $0.00 | +8,560 | 43.4K | +25% | $0 | |
| DM | 2024-02-21 | 2024-02-21 | EW | Chopra Daveen | CVP, TMTT | S - Sale+OE | $86.74 | -8,200 | 29.8K | -22% | -$711.3K |
| D | 2024-02-21 | 2024-02-21 | EW | Chopra Daveen | CVP, TMTT | M - OptEx | $59.26 | +7,000 | 30.9K | +29% | +$414.8K |
| M | 2024-02-20 | 2024-02-16+ | EW | Lippis Daniel J. | CVP, JAPAC | F - Tax | $86.08 | -545 | 17.6K | -3% | -$46.9K |
| 2024-02-16 | 2024-02-16 | EW | Wood Larry L | Gbl Pres TAVR, Surg | F - Tax | $86.04 | -317 | 213.5K | -0.1% | -$27.3K | |
| 2024-02-16 | 2024-02-16 | EW | Ullem Scott B. | CFO, CVP | F - Tax | $86.04 | -174 | 19.1K | -0.9% | -$15.0K | |
| DM | 2024-02-15 | 2024-02-13+ | EW | Szyman Catherine M. | CVP, Critical Care | S - Sale+OE | $85.98 | -47.0K | 34.8K | -57% | -$4.04M |
| DM | 2024-02-15 | 2024-02-13+ | EW | Szyman Catherine M. | CVP, Critical Care | M - OptEx | $36.75 | +47.0K | 61.8K | +317% | +$1.73M |
| DM | 2024-02-13 | 2024-02-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $85.83 | -11.0K | 39.5K | -22% | -$944.2K |
| D | 2024-02-13 | 2024-02-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $36.75 | +11.0K | 50.5K | +28% | +$404.2K |
| D | 2024-02-12 | 2024-02-12 | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | M - OptEx | $36.75 | +12.2K | 25.3K | +93% | +$448.7K |
| D | 2024-02-12 | 2024-02-12 | EW | SELLERS ROBERT W.A. | SVP, Corp. Ctrl | S - Sale+OE | $87.00 | -12.2K | 13.1K | -48% | -$1.06M |
| D | 2024-02-08 | 2024-02-08 | EW | STONE HEISZ LESLIE | Dir | S - Sale+OE | $86.45 | -7,056 | 27.0K | -21% | -$610.0K |
| D | 2024-02-08 | 2024-02-08 | EW | STONE HEISZ LESLIE | Dir | M - OptEx | $36.86 | +7,056 | 34.0K | +26% | +$260.1K |
| DM | 2024-02-05 | 2024-02-05 | EW | MUSSALLEM MICHAEL A | Dir | S - Sale+OE | $87.49 | -29.4K | 4,486 | -87% | -$2.57M |
| D | 2024-02-05 | 2024-02-05 | EW | MUSSALLEM MICHAEL A | Dir | M - OptEx | $36.75 | +29.4K | 33.8K | +654% | +$1.08M |
| D | 2024-02-01 | 2024-02-01 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +7,255 | 26.5K | +38% | +$266.6K |
| D | 2024-02-01 | 2024-02-01 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $78.29 | -7,255 | 19.2K | -27% | -$568.0K |
| D | 2024-01-12 | 2024-01-12 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $75.67 | -10.0K | 39.5K | -20% | -$756.7K |
| D | 2024-01-12 | 2024-01-12 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $36.75 | +10.0K | 49.5K | +25% | +$367.5K |
| DM | 2024-01-05 | 2024-01-05 | EW | MUSSALLEM MICHAEL A | Dir | S - Sale+OE | $72.98 | -29.4K | 4,486 | -87% | -$2.14M |
| D | 2024-01-05 | 2024-01-05 | EW | MUSSALLEM MICHAEL A | Dir | M - OptEx | $36.75 | +29.4K | 33.8K | +654% | +$1.08M |
| D | 2023-12-29 | 2023-12-29 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $76.55 | -14.5K | 19.2K | -43% | -$1.11M |
| D | 2023-12-29 | 2023-12-29 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +14.5K | 33.8K | +75% | +$533.2K |
| D | 2023-12-15 | 2023-12-15 | EW | Chopra Daveen | CVP, TMTT | M - OptEx | $59.26 | +7,000 | 30.9K | +29% | +$414.8K |
| D | 2023-12-15 | 2023-12-15 | EW | Chopra Daveen | CVP, TMTT | S - Sale+OE | $78.25 | -7,000 | 23.9K | -23% | -$547.8K |
| DM | 2023-12-13 | 2023-12-13 | EW | MUSSALLEM MICHAEL A | Dir | S - Sale+OE | $74.62 | -29.4K | 4,486 | -87% | -$2.19M |
| D | 2023-12-13 | 2023-12-13 | EW | MUSSALLEM MICHAEL A | Dir | M - OptEx | $36.75 | +29.4K | 33.8K | +654% | +$1.08M |
| D | 2023-12-13 | 2023-12-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $36.75 | +8,000 | 47.5K | +20% | +$294.0K |
| D | 2023-12-13 | 2023-12-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $71.86 | -8,000 | 39.5K | -17% | -$574.9K |
| D | 2023-12-13 | 2023-12-13 | EW | Wood Larry L | Gbl Pres TAVR, Surg | M - OptEx | $45.28 | +8,658 | 222.5K | +4% | +$392.0K |
| D | 2023-12-13 | 2023-12-13 | EW | Wood Larry L | Gbl Pres TAVR, Surg | S - Sale+OE | $71.86 | -8,658 | 213.8K | -4% | -$622.2K |
| D | 2023-12-06 | 2023-12-06 | EW | Chopra Daveen | CVP, TMTT | M - OptEx | $59.26 | +3,500 | 27.4K | +15% | +$207.4K |
| D | 2023-12-06 | 2023-12-06 | EW | Chopra Daveen | CVP, TMTT | S - Sale+OE | $70.00 | -3,500 | 23.9K | -13% | -$245.0K |
| D | 2023-11-13 | 2023-11-13 | EW | Wood Larry L | Gbl Pres TAVR, Surg | M - OptEx | $45.28 | +8,660 | 222.5K | +4% | +$392.1K |
| DM | 2023-11-13 | 2023-11-13 | EW | Wood Larry L | Gbl Pres TAVR, Surg | S - Sale+OE | $65.30 | -8,660 | 213.8K | -4% | -$565.5K |
| D | 2023-11-13 | 2023-11-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $36.75 | +6,000 | 45.5K | +15% | +$220.5K |
| DM | 2023-11-13 | 2023-11-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $65.30 | -6,000 | 39.5K | -13% | -$391.8K |
| D | 2023-11-06 | 2023-11-03 | EW | MUSSALLEM MICHAEL A | Dir | M - OptEx | $36.75 | +29.4K | 33.8K | +654% | +$1.08M |
| DMI | 2023-11-06 | 2023-11-06 | EW | MUSSALLEM MICHAEL A | Dir | G - Gift | $0.00 | 0 | 0 | New | $0 |
| D | 2023-11-06 | 2023-11-03 | EW | MUSSALLEM MICHAEL A | Dir | S - Sale+OE | $67.18 | -29.4K | 4,486 | -87% | -$1.97M |
| D | 2023-10-31 | 2023-10-31 | EW | Ullem Scott B. | CFO, CVP | M - OptEx | $36.75 | +7,255 | 26.5K | +38% | +$266.6K |
| D | 2023-10-31 | 2023-10-31 | EW | Ullem Scott B. | CFO, CVP | S - Sale+OE | $62.66 | -7,255 | 19.2K | -27% | -$454.6K |
| DM | 2023-10-13 | 2023-10-13 | EW | Wood Larry L | Gbl Pres TAVR, Surg | S - Sale+OE | $70.00 | -8,660 | 213.8K | -4% | -$606.2K |
| D | 2023-10-13 | 2023-10-13 | EW | Wood Larry L | Gbl Pres TAVR, Surg | M - OptEx | $45.28 | +8,660 | 222.5K | +4% | +$392.1K |
| DM | 2023-10-13 | 2023-10-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | S - Sale+OE | $69.98 | -5,000 | 42.5K | -11% | -$349.9K |
| D | 2023-10-13 | 2023-10-13 | EW | BOBO DONALD E JR | CVP, Strategy, Corp Development | M - OptEx | $36.75 | +5,000 | 44.5K | +13% | +$183.8K |
Purchase Sale Sale after option exercise All abbreviations